AI for biopharma business development: finding the right assets faster
By combining human expertise with AI-powered analysis, we’re helping biopharma companies make faster, more informed business development decisions.
By combining human expertise with AI-powered analysis, we’re helping biopharma companies make faster, more informed business development decisions.
Artificial intelligence-powered pipeline analysis is emerging as a tool that can help teams make better, faster drug development decisions.
Artificial Intelligence covers a range of algorithmic applications and outputs. Sometimes, AI hallucinates, so how does Vibe Bio deliver trustworthy outputs?
The Impact Review article explores Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases.
This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing.
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.